Torrent Pharma shares drop 4% amid block deal; promoter likely seller
Promoter Torrent Investments, which holds a 71.25% shares in Torrent Pharma, was looking to offload around 3% stake in the company.
Promoter Torrent Investments, which holds a 71.25% shares in Torrent Pharma, was looking to offload around 3% stake in the company.
The USFDA conducted the pre-approval inspection at the company’s oral-oncology manufacturing facility situated in Bileshwarpura, Gujarat from December 5 to December 11 last year.
The acquisition offers Torrent Pharma the opportunity to enhance its presence in dermatology with a differentiated portfolio.
Sun Pharma will sell Molnupiravir under the brand name Molxvir in India, Torrent Pharma will sell it as Molnutor, while Cipla will market it as Cipmolnu.